Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery. [electronic resource]
Producer: 20070330Description: 993-1001 p. digitalISSN:- 1552-6259
- Adrenergic beta-Antagonists -- therapeutic use
- Aged
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Cardiotonic Agents -- therapeutic use
- Coronary Artery Bypass -- adverse effects
- Female
- Heart Diseases -- prevention & control
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- etiology
- Platelet Aggregation Inhibitors -- therapeutic use
- Postoperative Care
- Proportional Hazards Models
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.